Table 2 Stage 1GLUT1 Enh2 and XbaI Risk genotype distributions among case and control subjects and odds ratio of albuminuria, by diabetes and race
| Â | European Americans | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Type 2 Diabetes | No Type 2 Diabetes | ||||||||
SNP | Controls | Cases | P-value | OR (95% CI) | Controls | Cases | P-value | OR (95% CI) | ||
Enh2 SNP (C > T) | 480 | 84 | Â | Â | Â | 1166 | 73 | Â | Â | Â |
   CC or CT | (94.6) | (88.1) | 0.025 | 1.00 |  | (94.7) | (93.1) | 0.574 | 1.00 |  |
   TT | (5.4) | (11.9) |  | 2.36 | (1.09 - 5.09)* | (5.3) | (6.9) |  | 1.31 | (0.51 - 3.36) |
XbaI SNP (C > A) †| 348 | 70 |  |  |  | 866 | 62 |  |  |  |
   CC or CA | (94.5) | (88.6) | 0.064 | 1.00 |  | (94.2) | (90.3) | 0.212 | 1.00 |  |
   AA | (5.5) | (11.4) |  | 2.23 | (0.94 - 5.33) | (5.8) | (9.7) |  | 1.75 | (0.72 - 4.25) |
| Â | African Americans | |||||||||
| Â | Type 2 Diabetes | No Type 2 Diabetes | ||||||||
SNP | Controls | Cases | P-value | OR (95% CI) | Controls | Cases | P-value | OR (95% CI) | ||
Enh2 SNP (C > T) | 217 | 80 | Â | Â | Â | 770 | 68 | Â | Â | Â |
   CC or CT | (99.5) | (100.0) | 0.543 | 1.00 |  | (99.7) | (100.0) | 0.674 | 1.00 |  |
   TT | (0.5) | (0.0) |  | N/A |  | (0.3) | (0.0) |  | N/A |  |
XbaI SNP (C > A) †| 190 | 73 |  |  |  | 654 | 59 |  |  |  |
   CC or CA | (81.6) | (80.8) | 0.888 | 1.00 |  | (82.6) | (78.0) | 0.376 | 1.00 |  |
   AA | (18.4) | (19.2) |  | 1.05 | (0.53 - 2.09) | (17.4) | (22.0) |  | 1.34 | (0.70 - 2.56) |